|
| 35878714 | A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 37595641 | Michigan Urology Academy-Our Role in Diversifying the Urology Workforce. | Urology | 2023 |
| 38067234 | Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 |
| 37566643 | Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice. | J Urol | 2023 |
| 37121355 | Intra-practice Urologist-level Variation in Targeted Fusion Biopsy Outcomes. | Urology | 2023 |
| 37085424 | Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. | Eur Urol | 2023 |
| 37232092 | Editorial Comment. | J Urol | 2023 |
| 37096582 | Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. | J Urol | 2023 |
| 37096575 | Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy. | J Urol | 2023 |
| 37471612 | Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer. | Cancer J | 2023 |
| 36585434 | MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. | Prostate Cancer Prostatic Dis | 2023 |
| 36898362 | NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. | J Natl Compr Canc Netw | 2023 |
| 34593595 | Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. | J Nucl Med | 2022 |
| 35719272 | Biomarkers for prostate cancer detection and risk stratification. | Ther Adv Urol | 2022 |
| 35817702 | Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For. | Eur Urol Focus | 2022 |
| 33812851 | Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer. | Eur Urol Oncol | 2022 |
| 35310961 | "PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer. | Kidney Cancer J | 2022 |
| 34906585 | Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need. | Urology | 2022 |
| 34753659 | Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. | Urol Oncol | 2022 |
| 34840106 | Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature. | Eur Urol Oncol | 2022 |
| 32631746 | Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. | Eur Urol | 2021 |
| 33563537 | Tumor size and genomic risk in localized prostate cancer. | Urol Oncol | 2021 |
| 34964855 | Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. | JAMA Netw Open | 2021 |
| 34673273 | Prostate cancer clinical trial completion: The role of geography. | Contemp Clin Trials | 2021 |
| 34217762 | Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation. | Urology | 2021 |
| 34288719 | Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities. | J Urol | 2021 |
| 34032495 | Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review. | J Urol | 2021 |
| 34337549 | Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [<sup>177</sup>Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer. | Eur Urol Open Sci | 2021 |
| 34337531 | Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study. | Eur Urol Open Sci | 2021 |
| 34280438 | Initial Findings from a High Genetic Risk Prostate Cancer Clinic. | Urology | 2021 |
| 33080150 | Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. | J Urol | 2021 |
| 32231245 | Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. | Prostate Cancer Prostatic Dis | 2020 |
| 35050780 | Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate. | JCO Precis Oncol | 2020 |
| 33168847 | Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors. | Sci Rep | 2020 |
| 30381857 | Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting. | Prostate | 2019 |
| 32832835 | Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer. | JCO Precis Oncol | 2019 |
| 32914029 | Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer. | JCO Precis Oncol | 2019 |
| 30153435 | International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy. | J Urol | 2019 |
| 30712974 | Unraveling Prostate Cancer Genomics, Pathology, and Magnetic Resonance Imaging Visibility. | Eur Urol | 2019 |
| 31120534 | Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. | JAMA Oncol | 2019 |
| 30730411 | Bringing Prostate Cancer Germline Genetics into Clinical Practice. | J Urol | 2019 |
| 30959121 | Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. | Int J Radiat Oncol Biol Phys | 2019 |
| 30506310 | Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. | J Racial Ethn Health Disparities | 2019 |
| 29174622 | Reply by the Authors. | Urology | 2018 |
| 29980330 | Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell Carcinoma. | Eur Urol | 2018 |
| 31100248 | Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure. | Eur Urol Oncol | 2018 |
| 30291535 | Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. | Med Oncol | 2018 |
| 30385730 | Transcriptomic heterogeneity in multifocal prostate cancer. | JCI Insight | 2018 |
| 29708949 | The genomics of renal cell carcinoma and its role in renal mass biopsy. | Curr Opin Urol | 2018 |
| 29306514 | Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival. | Eur Urol | 2018 |